Patten Group Inc. Has $1.40 Million Stock Holdings in Colgate-Palmolive (NYSE:CL)

Patten Group Inc. decreased its holdings in shares of Colgate-Palmolive (NYSE:CL) by 2.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 15,439 shares of the company’s stock after selling 361 shares during the period. Patten Group Inc.’s holdings in Colgate-Palmolive were worth $1,404,000 as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. D Orazio & Associates Inc. increased its position in shares of Colgate-Palmolive by 3.9% during the third quarter. D Orazio & Associates Inc. now owns 2,862 shares of the company’s stock valued at $297,000 after buying an additional 108 shares during the period. Commonwealth Financial Services LLC grew its stake in shares of Colgate-Palmolive by 4.5% during the fourth quarter. Commonwealth Financial Services LLC now owns 2,716 shares of the company’s stock valued at $247,000 after buying an additional 118 shares during the last quarter. Lantz Financial LLC increased its stake in Colgate-Palmolive by 0.6% in the 4th quarter. Lantz Financial LLC now owns 20,140 shares of the company’s stock worth $1,831,000 after purchasing an additional 122 shares during the period. Horizon Kinetics Asset Management LLC raised its holdings in Colgate-Palmolive by 4.2% during the 3rd quarter. Horizon Kinetics Asset Management LLC now owns 3,102 shares of the company’s stock valued at $322,000 after buying an additional 124 shares during the last quarter. Finally, Pine Haven Investment Counsel Inc boosted its holdings in shares of Colgate-Palmolive by 1.0% during the fourth quarter. Pine Haven Investment Counsel Inc now owns 13,006 shares of the company’s stock worth $1,182,000 after purchasing an additional 130 shares during the period. 80.41% of the stock is owned by institutional investors and hedge funds.

Colgate-Palmolive Trading Up 1.7 %

Shares of Colgate-Palmolive stock opened at $92.74 on Tuesday. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58. Colgate-Palmolive has a 1 year low of $85.32 and a 1 year high of $109.30. The business has a 50 day moving average price of $88.76 and a 200 day moving average price of $95.37. The company has a market capitalization of $75.26 billion, a P/E ratio of 26.35, a P/E/G ratio of 4.20 and a beta of 0.44.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period in the prior year, the business earned $0.87 earnings per share. Sell-side analysts anticipate that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, February 14th. Investors of record on Tuesday, January 21st were issued a $0.50 dividend. The ex-dividend date of this dividend was Tuesday, January 21st. This represents a $2.00 annualized dividend and a yield of 2.16%. Colgate-Palmolive’s dividend payout ratio is presently 56.82%.

Analyst Ratings Changes

A number of research analysts have recently commented on the company. Barclays lowered their target price on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a research note on Friday, January 17th. Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $101.00 price objective on shares of Colgate-Palmolive in a research note on Wednesday, January 29th. Stifel Nicolaus lowered their target price on shares of Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating on the stock in a report on Monday, February 3rd. Wells Fargo & Company reduced their price target on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a research report on Tuesday, January 7th. Finally, JPMorgan Chase & Co. decreased their price objective on Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating on the stock in a research report on Monday, February 3rd. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $101.61.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.